» Articles » PMID: 36770334

Melanoma Cell Reprogramming and Awakening of Antitumor Immunity As a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application

Overview
Date 2023 Feb 11
PMID 36770334
Authors
Affiliations
Soon will be listed here.
Abstract

In our recent study, we showed that treatment of melanoma cells with hyperpolarized light (HPL) as well as with the second derivative of fullerene, hyper-harmonized hydroxylated fullerene water complex (3HFWC) reduced viability of cells by decreasing their proliferative capacity and inducing senescence and reprogramming towards a normal, melanocytic phenotype. Therefore, we wanted to determine whether these effects persisted in the syngeneic mouse melanoma model with a combined treatment of HPL irradiation and 3HFWC . Our results demonstrated the potent antitumor effects of 3HFWC nanosubstance assisted by HPL irradiation. These effects were primarily driven by the stimulation of melanoma cell growth arrest, the establishment of a senescent phenotype, and melanocytic differentiation on the one hand, and the awakening of the antitumor immune response on the other. In addition, the combined treatment reduced the protumorigenic activity of immune cells by depleting T regulatory cells, myeloid-derived suppressors, and M2 macrophages. The support of the 3HFWC substance by HPL irradiation may be the axis of the new approach design based on tumor cell reprogramming synchronized with the mobilization of the host's protective immune response.

Citing Articles

Effect of Particle Size on Physical Properties, Dissolution, In Vitro Antioxidant Activity, and In Vivo Hepatoprotective Properties of Diels et Gilg Powders.

Zhang Z, Chen Y, Wang S, Tong Z, Luan F, Jiang B Pharmaceutics. 2024; 16(11).

PMID: 39598477 PMC: 11597285. DOI: 10.3390/pharmaceutics16111352.


Comparative Studies of the Structural and Physicochemical Properties of the First Fullerene Derivative FD-C (Fullerenol) and Second Fullerene Derivate SD-C (3HFWC).

Koruga D, Stankovic I, Matija L, Kuhn D, Christ B, Dembski S Nanomaterials (Basel). 2024; 14(5).

PMID: 38470808 PMC: 10935211. DOI: 10.3390/nano14050480.


The Second Derivative of Fullerene C (SD-C) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine.

Matija L, Stankovic I, Puric M, Milicic M, Maksimovic-Ivanic D, Mijatovic S Micromachines (Basel). 2023; 14(12).

PMID: 38138321 PMC: 10745578. DOI: 10.3390/mi14122152.


Editorial for Special Issue "Cancer Treatment via Nanotherapy".

Wang L Nanomaterials (Basel). 2023; 13(7).

PMID: 37049247 PMC: 10096838. DOI: 10.3390/nano13071153.

References
1.
Chen J, Fan T, Xie Z, Zeng Q, Xue P, Zheng T . Advances in nanomaterials for photodynamic therapy applications: Status and challenges. Biomaterials. 2020; 237:119827. DOI: 10.1016/j.biomaterials.2020.119827. View

2.
Dong H, Hu L, Li W, Shi M, He L, Wang C . Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8 T-cell mediated cytotoxicity in colorectal cancer. Mol Biol Rep. 2022; 49(6):4281-4292. PMC: 9262800. DOI: 10.1007/s11033-022-07262-y. View

3.
Mai T, Yoo S, Park S, Kim J, Choi K, Kim C . In Vivo Quantitative Vasculature Segmentation and Assessment for Photodynamic Therapy Process Monitoring Using Photoacoustic Microscopy. Sensors (Basel). 2021; 21(5). PMC: 7961824. DOI: 10.3390/s21051776. View

4.
Castano A, Mroz P, Hamblin M . Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer. 2006; 6(7):535-45. PMC: 2933780. DOI: 10.1038/nrc1894. View

5.
Lee E, Lim S, Lee M . Chitosan-coated liposomes to stabilize and enhance transdermal delivery of indocyanine green for photodynamic therapy of melanoma. Carbohydr Polym. 2019; 224:115143. DOI: 10.1016/j.carbpol.2019.115143. View